Vivregen

Vivregen was a U.S.-based animal health biotechnology company focused on regenerative tissue technologies for veterinary use. Its lead product, VIVR8, was described as a proprietary acellular regenerative fluid derived from factors secreted by stem cells from young developing tissue and was marketed for use in horses and companion animals. Publicly available information indicates the company operated out of Illinois and promoted case-based use in conditions such as lameness, tendon injury, DSLD, and other veterinary disorders. The company appears to have been small and privately held, and an affiliated entity, Vivregen Animal Health, LLC, is listed as voluntarily dissolved. Current evidence for an active operating business is limited, so the company appears inactive or effectively defunct.